Laurie Mcgraw is Director of Augmedix, Inc.. Currently has a direct ownership of 0 shares of AUGX, which is worth approximately $0. The most recent transaction as insider was on Oct 02, 2024, when has been sold 74,230 shares (Common Stock) at a price of $2.35 per share, resulting in proceeds of $174,440. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

LAURIE MCGRAW Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 02 2024
SELL
Sale (or disposition) back to the issuer
$174,440 $2.35 p/Share
74,230 Reduced 100.0%
0 Common Stock
Jul 13 2024
BUY
Exercise of conversion of derivative security
-
21,598 Added 22.54%
74,230 Common Stock
Jun 16 2023
BUY
Exercise of conversion of derivative security
-
52,632 Added 50.0%
52,632 Common Stock

Also insider at

MDVL
MedAvail Holdings, Inc. Healthcare
LM

Laurie Mcgraw

Director
San Francisco, CA

Track Institutional and Insider Activities on AUGX

Follow Augmedix, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUGX shares.

Notify only if

Insider Trading

Get notified when an Augmedix, Inc. insider buys or sells AUGX shares.

Notify only if

News

Receive news related to Augmedix, Inc.

Track Activities on AUGX